News

View all
Thumbnail image for SMC OKs four new therapies for NHS use in Scotland

SMC OKs four new therapies for NHS use in Scotland

Cost regulators in Scotland have approved NHS funding for four new medicines, expanding treatment options for lung cancer, iron excess, hepatitis C and chronic pain, but Janssen's Darzalex was rejected for multiple myeloma.

17th January 2017

Thumbnail image for AZ expands first-line cancer immunotherapy programme

AZ expands first-line cancer immunotherapy programme

AstraZeneca has expanded a late-stage trial currently assessing a potential new immuno-oncology (IO) therapy combination for the first-line treatment of non-small cell lung cancer (NSCLC), to include extra endpoints for both the combo and monotherapy.

17th January 2017

Thumbnail image for DH invests £35m in vaccines for global epidemics

DH invests £35m in vaccines for global epidemics

The Department of Health is launching a competition later this month offering up to a total of £35 million to help small businesses progress development of new vaccines against infectious diseases.

17th January 2017

Web Exclusives

View all
Thumbnail image for Thinking alike

Thinking alike

How can pharma help the NHS achieve Parity of Esteem in mental health?

Thumbnail image for Difficult breathing

Difficult breathing

Mesothelioma expert Dr Raja Flores on the state of treatment for this often neglected disease

Thumbnail image for A new way in

A new way in

The ins and out of the controversial proposed changes to NICE and its HST assessments

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download